Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$0.71 USD
+0.03 (4.89%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.72 +0.01 (0.71%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.37 | 33.04% |
Earnings Summary
For their last quarter, Atara Biotherapeutics (ATRA) reported earnings of -$0.56 per share, beating the Zacks Consensus Estimate of $-0.61 per share. This reflects a positive earnings surprise of 8.20%. Look out for ATRA's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year increase of 48.61%.
Earnings History
Price & Consensus
Zacks News for ATRA
Fulcrum Therapeutics, Inc. (FULC) Reports Q4 Loss, Tops Revenue Estimates
ATRA: What are Zacks experts saying now?
Zacks Private Portfolio Services